Abstract: Polyfluorinated compounds are disclosed, including polyfluorinated cannabinoid and cannabinoid-like compounds. Also disclosed are methods of producing the polyfluorinated compounds.

Abstract: The present invention is directed to compounds, tautomers, stereoisomers, and chemically modified compounds thereof, and their use in preventing and/or treating tumors of metastasis and/or cartilage defect, and to a pharmaceutical composition comprising such compound.

Abstract: A photosensitizer-containing dispersion, and use thereof.

Abstract: The present invention is directed to compounds, tautomers, stereoisomers, and chemically modified compounds thereof, and their use in preventing and/or treating tumors of metastasis and/or cartilage defect, and to a pharmaceutical composition comprising such compound.

Abstract: The present invention relates, to metal complexes having improved solubility, to processes for the preparation of the metal complexes, to devices comprising these metal complexes and to the use of the metal complexes.

Abstract: The present invention relates, inter alia, to metal complexes having improved solubility, to processes for the preparation of the metal complexes, to devices comprising these metal complexes and to the use of the metal complexes.

Abstract: The present invention relates, inter alia, to metal complexes having improved solubility, to processes for the preparaion of the metal complexes, to devices comprising these metal complexes and to the use of the metal complexes.

Abstract: The present invention relates inter alia to a new class of metal complexes comprising 1,2,3-triazoles having improved solubility and enhanced electro-optical properties. The present invention further relates to the preparation and use of these compounds.

Abstract: The present invention relates, inter alia, to metal complexes having improved solubility, to processes for the preparaion of the metal complexes, to devices comprising these metal complexes and to the use of the metal complexes.

Abstract: The present invention relates to peptides and antibodies which bind to melanoma inhibitory activity protein and the uses of such peptides and antibodies. The invention also relates to nucleic acids coding for such peptides or antibodies. The invention also relates to pharmaceutical compositions comprising such peptides or antibodies or such nucleic acids. The present invention also relates to small molecule compounds which bind to melanoma inhibitory activity protein and to uses of such small molecule compounds. Moreover, the present invention also relates to a method of preventing dimerization and/or aggregation of melanoma inhibitory activity (MIA) protein. The invention is based on the identification of the relevant sites of interaction of the MIA protein with the inhibitory peptides/antibodies.

Abstract: A conveyor belt is described having a woven fabric backing which includes staple fiber yarn and includes a twill weave with an inclination angle of 10.degree. to 70.degree. relative to the moving direction of the conveyor belt, and in which adjacent yarns have the same direction of lay. In the woven fabric backing the staple fiber yarn is provided as warp yarn, each of which has the same direction of lay in its longitudinal direction, and adjacent yarns of which are alternately S and Z twisted. Additionally, elements which support the tensile forces are arranged in the conveyor belt, the elements being arranged in a woven fabric or being sheathed as threads by staple fibers. Since the staple fiber yarn of the warp of the woven fabric backing extends diagonally over the entire width of the conveyor belt, an endless support results even when the belt runs over an edge, and an absolutely uniform vibration-free conveyor belt movement having a low noise level is achieved even when the belt passes over an edge.